There are 3 papers on abdominal visceral fat mass in aging research: 2 trials and 1 observational study in people.
3 papers study it1 more mentions it1 finding
“higher AVF predicted reduced l-arginine-stimulated GH secretion (R(2) = 0.46, P = 0.0013)”
- Human trial2
- Humans1
Associations
1L-arginine-stimulated growth hormone secretion
downin humans1
1 study
L-arginine-stimulated growth hormone secretion
downin humans1
Abdominal visceral fat mass predicts L-arginine-stimulated growth hormone secretion in humans (combined pre- and postmenopausal cohorts) (R(2) = 0.46, P = 0.0013).
“higher AVF predicted reduced l-arginine-stimulated GH secretion (R(2) = 0.46, P = 0.0013)”
Human trialcombined pre- and postmenopausal cohortsfemales
Tripartite control of growth hormone secretion in women during controlled estradiol repletion
The Journal of clinical endocrinology and metabolism
Latest
The Journal of Clinical Endocrinology and Metabolism
Tripartite control of growth hormone secretion in women during controlled estradiol repletion
Study of 10 peopleGrowth hormone axis
The Journal of Clinical Endocrinology and Metabolism
Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial
Randomized trial in 40 peopleAbdominal obesity
The Journal of Clinical Endocrinology and Metabolism
Dual secretagogue drive of burst-like growth hormone secretion in postmenopausal compared with premenopausal women studied under an experimental estradiol clamp
Non-randomized trial in peopleGrowth hormone axis
Endocrine Connections
Interleukin-2 drives cortisol secretion in an age-, dose-, and body composition-dependent way
Trial in peopleMechanisms